Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04664465
Status:
UNKNOWN
Last Update Posted:
2022-05-09
First Post:
2020-12-06
Brief Title:
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
Sponsor:
University Hospital Brest
Organization:
University Hospital Brest
Study Overview
Official Title:
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRODIGIOUS
Brief Summary:
To date there is no available tool that allows at individual level determination of the probability to develop clinically relevant complications of prolonged glucocorticoid therapy In patients with inflammatory rheumatic disorders requiring prolonged glucocorticoid therapy such tool could be useful to adapt first-line treatment decisions in daily practice and in future clinical trials The main objective of the study is to identify routine clinical biological and DXA baseline characteristics predictive of the occurrence of clinically relevant complications of glucocorticoid therapy at 1 year in order to propose a predictive score
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None